TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX/CRDL

Cardiol Therapeutics Inc Class A (CRDL : TSX)

Common Stock

$2.70

CAD

+0.09 (3.45%)

Last updated: 2026-08-19

Get CRDL alerts:

CRDL

Cardiol Therapeutics Inc Class A

Source:WealthAwesomeWealthAwesome
$1.26 (87.50%)
30 day period
$1.44$2.07$2.70Jul 8Jul 29Aug 19

Performance

1 Day

+3.45%

1 Week

+27.36%

1 Month

+54.29%

YTD

+98.53%

Key Statistics

Market Cap

$304.91M

52W High

$2.70

52W Low

$1.23

P/E Ratio

-

50 Day MA

$1.70

200 Day MA

$1.59

Beta

0.47

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
8/19/2026$2.65$2.70$2.57$2.70$2.70290,574
8/18/2026$2.52$2.63$2.42$2.61$2.61218,837
8/17/2026$2.47$2.69$2.45$2.49$2.49351,870
8/14/2026$2.35$2.53$2.29$2.51$2.51407,983
8/13/2026$2.12$2.45$2.09$2.42$2.42360,761
8/12/2026$2.10$2.12$2.00$2.12$2.12236,800
8/11/2026$2.07$2.12$2.02$2.11$2.11151,752
8/10/2026$1.99$2.09$1.93$2.06$2.06264,754
8/7/2026$1.91$1.99$1.89$1.99$1.99127,972
8/6/2026$1.88$1.94$1.85$1.93$1.93130,571

Analyst Price Targets

Based on analyst covering CRDL

📈

Wall Street analysts forecast CRDL stock price to rise 122.2% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.00

+122.2% Upside

Current Price

C$2.70

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CRDL's historical volatility

HistoricalForecast68%95%
C$1.39C$2.61C$3.84C$5.06C$6.28C$7.51TodayApr 13Jun 16Aug 19Oct 1Nov 14Dec 27

30-Day Vol

68.2%

Annualized

90-Day Vol

58.8%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$3.23

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$2.87C$2.27C$3.63
60 trading daysC$3.04C$2.18C$4.24
90 trading daysC$3.23C$2.15C$4.85

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-35.57M
Profit Margin
0.00%
ROE (TTM)
-173.96%
EPS (Diluted)
-0.34
Book Value
0.22

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About CRDL

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
DIAMStar Diamond Corp$0.02+33.33%
SSherritt International Corporation$0.47+21.79%
ORIOOrion Digital Corp.$1.30+18.18%
ASTLAlgoma Steel Group Inc$6.60+16.61%
FTFortune Minerals Limited$0.15+15.38%
CJR-BCorus Entertainment Inc$0.04+14.29%
STLRSTLLR Gold Inc.$1.87+13.33%
NGNovaGold Resources Inc$11.67+13.19%

CRDL.TO news timeline

15 articles covering CRDL.TO, most recent first

Latest

Why Cardiol Therapeutics Inc Class A stock went up yesterday

Stocks

Advertisement